Therapeutic Application of Corticosteroids in COVID-19: A Focus on Optimum Dose and Duration of Therapy.

Khiali, Sajad; Entezari-Maleki, Taher

Khiali, Sajad; Entezari-Maleki, Taher.

Khiali S; Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Entezari-Maleki T; Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

J Clin Pharmacol ; 61(9): 1145-1148, 2021 09.

Article in English | MEDLINE | ID: covidwho-1279375

Subject(s)

COVID-19; Adrenal Cortex Hormones; Dexamethasone; Duration of Therapy; Humans; SARS-CoV-2

Keywords

COVID-19; SARS-CoV-2; acute respiratory distress syndrome (ARDS); corticosteroid; cytokine release syndrome; dexamethasone; methylprednisolone

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: J Clin Pharmacol Year: 2021 Document Type: Article Affiliation country: Jcph.1929

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google